Company IPI Legacy Liquidation Co

Equities

Inactive Instrument

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

Delayed OTC Markets Other stock markets 11:38:57 05/04/2024 pm IST			5-day change	1st Jan Change
0.015 ^USD	-.--%		-.--%	-87.85%

12/04	North American Morning Briefing : Big Banks Kick -2-	DJ
05/04	North American Morning Briefing : Investors on -2-	DJ

IPI Legacy Liquidation Co, formerly Impel Pharmaceuticals Inc., is not engaged in any business operations. The Company doesnât hold any assets.

Number of employees: 160

Managers	Title	Age	Since
John D. Hoekman FOU	Founder	43	01/08/01
Sheena Aurora CTO	Chief Tech/Sci/R&D Officer	-	-
Scott Youmans CTO	Chief Tech/Sci/R&D Officer	57	-
Sarah Wille HRO	Human Resources Officer	-	01/19/01
Lynn Gold LAW	General Counsel	67	01/18/01

Members of the board	Title	Age	Since
Timothy Nelson BRD	Director/Board Member	60	01/17/01
Ali Satvat BRD	Director/Board Member	46	07/18/07
Diane Wilfong BRD	Director/Board Member	62	17/19/17
David Allison BRD	Director/Board Member	42	01/19/01
John D. Hoekman FOU	Founder	43	01/08/01
Darren Cline BRD	Director/Board Member	59	12/23/12

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	23,900,031	21,120,240 ( 88.37 %)	0	88.37 %

Impel Pharmaceuticals, Inc.

201 Elliott Avenue West Suite 260

98119, Seattle

+206 568 1466

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+0.67%	42.19B
LONZA GROUP AG	+44.30%	40.15B
CELLTRION, INC.	-6.20%	28.31B
ICON PUBLIC LIMITED COMPANY	+6.55%	24.63B
ALNYLAM PHARMACEUTICALS, INC.	-21.66%	18.2B
MEDPACE HOLDINGS, INC.	+29.96%	12.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.57%	11.76B
UNITED THERAPEUTICS CORPORATION	+16.03%	10.4B
BIO-TECHNE CORPORATION	-4.80%	9.94B